Natural Alternatives International (NAII) Competitors $4.12 -0.03 (-0.84%) As of 02/21/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends NAII vs. CLYM, ZURA, ANIX, CRDL, XBIT, MGX, ELUT, ALTS, ORMP, and MNOVShould you be buying Natural Alternatives International stock or one of its competitors? The main competitors of Natural Alternatives International include Climb Bio (CLYM), Zura Bio (ZURA), Anixa Biosciences (ANIX), Cardiol Therapeutics (CRDL), XBiotech (XBIT), Metagenomi (MGX), Elutia (ELUT), Janone (ALTS), Oramed Pharmaceuticals (ORMP), and MediciNova (MNOV). These companies are all part of the "pharmaceutical products" industry. Natural Alternatives International vs. Climb Bio Zura Bio Anixa Biosciences Cardiol Therapeutics XBiotech Metagenomi Elutia Janone Oramed Pharmaceuticals MediciNova Climb Bio (NASDAQ:CLYM) and Natural Alternatives International (NASDAQ:NAII) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability, community ranking, valuation and media sentiment. Which has higher valuation & earnings, CLYM or NAII? Natural Alternatives International has higher revenue and earnings than Climb Bio. Natural Alternatives International is trading at a lower price-to-earnings ratio than Climb Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioClimb BioN/AN/A-$35.12M-$2.13-0.70Natural Alternatives International$113.80M0.23-$7.22M-$1.29-3.26 Does the MarketBeat Community believe in CLYM or NAII? Natural Alternatives International received 265 more outperform votes than Climb Bio when rated by MarketBeat users. However, 100.00% of users gave Climb Bio an outperform vote while only 76.29% of users gave Natural Alternatives International an outperform vote. CompanyUnderperformOutperformClimb BioOutperform Votes2100.00% Underperform VotesNo VotesNatural Alternatives InternationalOutperform Votes26776.29% Underperform Votes8323.71% Which has more risk & volatility, CLYM or NAII? Climb Bio has a beta of -0.24, indicating that its share price is 124% less volatile than the S&P 500. Comparatively, Natural Alternatives International has a beta of 0.62, indicating that its share price is 38% less volatile than the S&P 500. Do institutionals & insiders have more ownership in CLYM or NAII? 69.8% of Climb Bio shares are owned by institutional investors. Comparatively, 32.4% of Natural Alternatives International shares are owned by institutional investors. 3.2% of Climb Bio shares are owned by insiders. Comparatively, 20.9% of Natural Alternatives International shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media refer more to CLYM or NAII? In the previous week, Natural Alternatives International had 1 more articles in the media than Climb Bio. MarketBeat recorded 1 mentions for Natural Alternatives International and 0 mentions for Climb Bio. Climb Bio's average media sentiment score of 0.00 equaled Natural Alternatives International'saverage media sentiment score. Company Overall Sentiment Climb Bio Neutral Natural Alternatives International Neutral Do analysts rate CLYM or NAII? Climb Bio presently has a consensus target price of $10.00, indicating a potential upside of 568.90%. Given Climb Bio's stronger consensus rating and higher possible upside, research analysts plainly believe Climb Bio is more favorable than Natural Alternatives International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Climb Bio 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50Natural Alternatives International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is CLYM or NAII more profitable? Climb Bio has a net margin of 0.00% compared to Natural Alternatives International's net margin of -6.26%. Natural Alternatives International's return on equity of -9.36% beat Climb Bio's return on equity.Company Net Margins Return on Equity Return on Assets Climb BioN/A -42.21% -41.39% Natural Alternatives International -6.26%-9.36%-4.82% SummaryNatural Alternatives International beats Climb Bio on 9 of the 17 factors compared between the two stocks. Get Natural Alternatives International News Delivered to You Automatically Sign up to receive the latest news and ratings for NAII and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAII vs. The Competition Export to ExcelMetricNatural Alternatives InternationalMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$25.73M$1.16B$5.84B$9.14BDividend YieldN/AN/A4.75%3.86%P/E Ratio-3.2635.7826.7719.18Price / Sales0.235.72435.4570.78Price / CashN/A10.4038.0134.83Price / Book0.331.927.644.62Net Income-$7.22M-$53.22M$3.19B$246.06M7 Day Performance1.45%-5.53%-2.12%-2.63%1 Month Performance-0.47%-1.92%-0.45%-2.15%1 Year Performance-31.43%-13.79%16.26%12.88% Natural Alternatives International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAIINatural Alternatives International0.3762 of 5 stars$4.21+1.4%N/A-30.4%$25.73M$113.80M-3.26290Earnings ReportAnalyst ForecastCLYMClimb Bio2.4956 of 5 stars$1.52-4.4%$10.00+557.9%N/A$102.17MN/A-0.719ZURAZura Bio2.8396 of 5 stars$1.55+3.3%$15.80+919.4%-62.0%$101.20MN/A0.003Gap UpANIXAnixa Biosciences2.9956 of 5 stars$3.14-0.3%$8.50+170.7%-18.3%$101.11M$210,000.00-8.055Analyst ForecastAnalyst RevisionNews CoverageCRDLCardiol Therapeutics2.8824 of 5 stars$1.22-1.6%$8.40+588.5%-18.4%$100.78MN/A-3.1320News CoverageXBITXBiotech0.5161 of 5 stars$3.27+1.9%N/A-56.7%$99.67M$4.01M-3.03100MGXMetagenomi1.8766 of 5 stars$2.61+6.5%$16.67+538.6%-79.1%$97.67M$44.76M0.00236News CoverageELUTElutia3.6048 of 5 stars$2.82-1.4%$10.00+254.6%-13.0%$97.46M$24.75M-1.08180News CoverageGap UpALTSJanoneN/A$6.90+10.6%N/AN/A$97.08M$39.61M0.00170News CoverageORMPOramed Pharmaceuticals1.4757 of 5 stars$2.40-2.0%N/A-33.0%$96.74M$1.34M21.8210Analyst DowngradeMNOVMediciNova2.4398 of 5 stars$1.97+5.3%$9.00+356.9%+35.6%$96.63M$1M-9.3810Earnings ReportAnalyst ForecastNews CoverageHigh Trading Volume Related Companies and Tools Related Companies Climb Bio Competitors Zura Bio Competitors Anixa Biosciences Competitors Cardiol Therapeutics Competitors XBiotech Competitors Metagenomi Competitors Elutia Competitors Janone Competitors Oramed Pharmaceuticals Competitors MediciNova Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NAII) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredThis quote from Elon says it all… (AI Breakthrough)MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | Sponsored2025 AI Blueprint features Nvidia’s march to $5 trillionNvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredHas Trump finally met his match?A new Chinese AI software called "DeepSeek" is sending shockwaves through the market. It's advanced enough ...Behind the Markets | SponsoredShocking Elon Move: Bigger than DOGE?After saving free speech with his acquisition of Twitter… And after blowing everyone’s minds with his recen...Brownstone Research | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natural Alternatives International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Natural Alternatives International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.